ReVasc Technologies

ReVasc Technologies was a medical device company focused on developing innovative solutions for the treatment of complex vascular diseases, specifically chronic total occlusions (CTO). The company's primary product was the ReVasc system, a specialized catheter-based technology designed to facilitate the crossing of completely blocked arteries in both peripheral and coronary applications. By providing interventional cardiologists and vascular surgeons with more effective tools for revascularization, ReVasc aimed to reduce the need for invasive bypass surgeries. The company was eventually acquired, and its technology was integrated into the portfolio of a larger cardiovascular device manufacturer.